Midodrin Substipharm 2,5 mg, comprimés

7680693840065 CH-69384 Tabletten

No image available

Article details

Package size
50
Selling units
50
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/02/2026
Patient information leaflet
Français
10/02/2026
Patient information leaflet
Italien
10/02/2026
Summary of Product Characteristics
Allemand
10/02/2026
Summary of Product Characteristics
Français
10/02/2026
Summary of Product Characteristics
Italien
10/02/2026

Detailed composition

Substance Quantity Type Category
midodrini hydrochloridum
2.5 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK

Authorization holder

Leman SKL SA

1213 Lancy

Authorization information

Swissmedic authorization number
69384
Drug name
Midodrin Substipharm, comprimés
Galenic form
TAB
ATC Code
C01CA17
Authorization status
Z
Dispensing category
B
First authorization
22/01/2025
Authorization expiration date
21/01/2030
IT Number
02.05.2.
Domain
Human medicine

Package details

Description (FR)
MIDODRIN Substipharm 2,5 mg cpr 2.5 mg 50 pce
Description (DE)
MIDODRIN Substipharm 2,5 mg Tabl 2.5 mg 50 Stk
Market launch
01/09/2026
Narcotic (BTM)
No

Other package sizes (7)

None
20 TABL
GTIN: None
Not in V1
None
50 TABL
GTIN: None
Not in V1
MIDODRIN Substipharm 2,5 mg cpr 2.5 mg 20 pce
20 TABL
GTIN: 7680693840058
View
None
20 TABL
GTIN: None
Not in V1
None
50 TABL
GTIN: None
Not in V1
None
20 TABL
GTIN: None
Not in V1
None
50 TABL
GTIN: None
Not in V1
Buy us a coffee Explore the data